Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sofosbuvir+RBV or LDV/SOF in HCV with Renal Insufficiency
NCT01958281Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Oct 2013
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of sofosbuvir, ledipasvir in hepatitis C (HCV), sponsored by Gilead Sciences. Started Oct 2013; status: completed.
02
Drugs
sofosbuvirledipasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01958281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01958281.